Summary
The activity of monoamine oxidase-A was found to be lower in homogenates of hypothalamus and caudate nucleus, but not in cortex of the gyrus cinguli and hippocampus, from chronic alcoholics with respect to homogenates from autopsy cases without histories of alcohol abuse. The activity of monoamine oxidase -B was also lower in the alcoholics, but this could be due to the selective effect of age upon this enzyme form, since the alcoholics were younger than controls. No difference was found for either monoamine oxidase -A or -B activities in brain homogenates from an alcohol preferring (AA) strain of rats, with respect to those from a water preferring (ANA) strain.
Similar content being viewed by others
References
Adolfsson, R., Gottfries, C-G., Roos, B-G., Winblad, B.: Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm.45, 81–105 (1979).
Adolfsson, R., Gottfries, C-G., Oreland, L., Wiberg, Å., Winblad, B.: Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci.27, 1029–1034 (1980).
Bergman, H., Borg, S., Hindmarsh, T., Ideström, C-M., Mützell, S.: Computed tomography of the brain and neuropsychological assessment of male alcoholics. In: Addiction and brain damage (Richter, D., ed.), pp. 201–214. London: Croom Helm. 1980.
Bolter, J. F., Hannon, R.: Cerebral damage associated with alcoholism: A re-examination. The Physiological Record30, 165–179 (1980).
Buchsbaum, M. S., Coursey, R. D., Murphy, D. L.: The biological highrisk paradign: Behavioural and familial correlates of low platelet monoamine oxidase activity. Science194, 339–341 (1976).
Buchsbaum, M. S., Haier, R. J., Murphy, D. L.: Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta psychiat. scand.56, 69–79 (1977).
Campbell, I. C., Marangos, P. sJ., Murphy, D. L., Plarse, A. G. E.: Neuronspecific enolase (NSE) in human blood platelets: Implications for the neuronal model. In: Recent Advances in Neuropsychopharmacology. Advances in the Biosciences (Angrist, B., Burrows, G. D., Lader, M., Lingjaerde, O., Sedvall, G., Wheatley, D.), Vol. 31, pp. 203–211. Oxford: Pergamon Press. 1981.
Carlsson, A., Fowler, C. J., Magnusson, T., Oreland, L., Wiberg, Å.: The activities of monoamine oxidase -A and -B, succinate dehydrogenase and acid phosphate in the rat brain after hemitransektion. Naunyn-Schmiedeberg's Arch. Pharmacol.316, 51–55 (1981).
Donnelly, C. H., Murphy, D. L.: Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem. Pharmacol.26, 853–858 (1977).
Eckert, B., Gottfries, C.-G., von Knorring, L., Oreland, L., Wiberg, Å., Winblad, B.: Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. Progr. Neuropsychopharmacol.4, 57–68 (1980).
Eriksson, K.: Factors affecting voluntary alcohol consumption in the albino laboratory rat. Ann. Zool. Fennici6, 227–265 (1969).
Eriksson, K.: Inherited metabolism and behaviour towards alcohol: Critical evaluation of human and animal research. In: Animal Models in Alcohol Research (Eriksson, K., Sinclair, J. D., Kiianmaa, K.), Proc. Int. Conf, Helsinki 1979, pp. 3–20. London: Academic Press. 1980.
Fowler, C. J., Oreland, L.: Substrate- and steroselective inhibition of human brain monoamine oxidase by 4-dinethylamino-α, 2-dinethylphenethylamine (FLA 336). J. Pharm. Pharmacol.33, 403–406 (1981).
Fowler, C. J., Tipton, K. F.: Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J. Neurochem.38, 733–736 (1982).
Fowler, C. J., Wiberg, Å., Oreland, L., Marcusson, J., Winblad, B.: The effect of age on the activity and molecular properties of human brain monoamine oxidase. J. Neural Transm.49, 1–20 (1980).
Fowler, C. J., Wiberg, Å., Oreland, L., Danielsson, Å., Palm, U., Winblad, B.: Monoamine oxidase activity and kinetic properties in platelet-rich plasma from controls, chronic alcoholics and patients with severe nonalcoholic liver-damage. Biochem. Med.25, 356–365 (1981).
Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B.: Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem.25, 667–673 (1975).
Gottfries, C.-G., von Knorring, L., Oreland, L.: Platelet monoamine oxidase activity in mental disorders 2. Affective psychoses and suicidal behavior. Progr. Neuropsychopharmacol.4, 185–192 (1980).
Hudolin, V.: Impairments of the nervous system in alcoholics. In: Addiction and Brain Damage (Richter, ed.), pp.168–200. London: Croom Helm. 1980.
Jain, M., Bakutis, E., Gayle, T., Lansky, P.: Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4). Neurobiology4, 180–190 (1974).
Johnston, J. P.: Some observations on a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol.17, 1285–1297 (1968).
Kinemuchi, H., Wakui, Y., Toyoshima, Y., Hayashi, N., Kamijo, L.:β-phenethylamine (PEA), a concentration dependent preferential substrate for multiple forms of MAO. In: Monoamine Oxidase: Structure, Function and Altered Functions (Singer, T. P., von Korjf, R. W., Murphy, P. L., eds.), pp. 205–212. New York: Academic Press. 1979.
Knoll, J., Magyar, K.: Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol.5, 393–408 (1972).
Kurosawa, Y.: Studies on monoamine oxidase (Report XXV). Effects on alcohols on beef liver mitochondrial monoamine oxidase. Jap. Pharmacol.24, 787–795 (1974).
Lancet Editorial: Alcoholic brain damage. Lancet1, 477–478 (1981).
Lishman, W. A., Ron, M., Acker, W.: Computed tomography of the brain and psychometric assessment of alcoholic patients-a British study. In: Addiction and Brain Damage (Richter, D., ed.), pp. 215–227. London: Croom Helm. 1980.
Lusins, J., Zimberg S., Smokler, H., Gurley, K.: Alcoholism and cerebral atrophy: A study of 50 patients with CT scan and psychologic testing. Alcoholism: Clin. Exp. Res.4, 406–411 (1980).
Mackay, A. V. P., Davies, P., Dewar, A. J., Yates, C. M.: Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J. Neurochem.30, 827–839 (1978).
Major, L. F., Murphy, D. L.: Platelet and plasma monoamine oxidase activity in alcoholic individuals. Br. J. Psychiat.132, 548–554 (1978).
Oreland, L.: The activity of human brain and platelet monoamine oxidase (MAO) in relation to various psychiatric disorders. I. MAO activity in some disease states. In: Monoamine Oxidase: Structure, Function and Altered Functions (Singer, T. P., von Korff, R. W., Murphy, D., eds.), pp. 379–387. New York: Academic Press. 1979.
Oreland, L., Wiberg, Å., Fowler, C. J.: Monoamine oxidase activity in platelets as related to monoamine oxidase activity and monoaminergic function in the brain. In: Recent Advances in Neuropsychopharmacology. (Advances in the Biosciences, Vol. 31.) (Angrist, B., ed.), pp. 195–201. Oxford: Pergamon Press. 1981.
Puchall, L. B., Cousey, R. D., Buchsbaum, M. S., Murphy, D. L.: Parents of high risk subjects defined by levels of monoamine oxidase activity. Schizophrenia Bull.6, 338–346 (1980).
Robinson, D. S., Nies, A.: Demographic, biologic and other variables affecting monoamine oxidase activity. Schizophrenia Bull.6, 298–307 (1980).
Romanowa, L. A.: Effect of acute and chronic administration of ethanol on monoamine oxidase activity in rat brain and liver tissues. Vopr. Med. Khim.26, 252–255 (1980).
Roth, J. A.: Evidence for a single catalytic binding site on human brain type B monoamine oxidase. J. Neurochem.27, 1107–1112 (1976).
Stahl, S. M.: The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiat.34, 509–516.
Sullivan, J. L., Stanfield, C. N., Maltbie, A. A., Hammett, E., Cavenar J. O.: Stability of blood platelet monoamine oxidase activity in human alcoholics. Biol. Psychiat.13, 391–397 (1978).
Suzuki, O., Katsumata, Y., Oya, M., Matsumoto, I.: Effect ofβ-phenethylamine concentration on its substrate specificity for type A and B monoamine oxidase. Biochem. Pharmacol.28, 953–956 (1979).
White, H. L., Glassman, A. T.: Multiple binding of human brain and liver monoamine oxidase: Substrate specificities, selective inhibitors, and attempts to separate enzyme forms. J. Neurochem.29, 987–997 (1977).
Wiberg, Å.: Mitochondrial Monoamine Oxidase. Studies on its activity in some psychiatric diseases. In: Umeå University Medical Dissertations, New Series no 41. Umeå 1978.
Wiberg, Å., Gottfries, C-G., Oreland, L.: Low platelet monoamine oxidase activity in human alcoholics. Med. Biol.55, 181–186 (1977 a).
Wiberg, Å, Wahlström, G., Oreland, L.: Brain monoamine oxidase activity after chronic ethanol treatment of rats. Psychopharmacol.52, 111–113 (1977 b).
Yang, H-Y. T., Neff, N. H.:β-phenethylamine: A specific substrate for type B monoamine oxidase of brain. J. Pharmacol, exp. Therap.187, 365–371 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oreland, L., Wiberg, Å., Winblad, B. et al. The activity of monoamine oxidase -A and -B in brains from chronic alcoholics. J. Neural Transmission 56, 73–83 (1983). https://doi.org/10.1007/BF01243375
Issue Date:
DOI: https://doi.org/10.1007/BF01243375